Manchester Capital Management’s Guardant Health GH Stock Holding History

Manchester Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$151	Buy	+1	New	+$109	﹤0.01%	1292
2025 Q3	–	Sell	-2,740	Closed	-$143K	–	1314
2025 Q2	$143K	Hold	2,740	–	–	0.02%	401
2025 Q1	$117K	Hold	2,740	–	–	0.01%	411
2024 Q4	$83.7K	Hold	2,740	–	–	0.01%	452
2024 Q3	$62.9K	Hold	2,740	–	–	0.01%	491
2024 Q2	$79.1K	Hold	2,740	–	–	0.01%	437
2024 Q1	$56.5K	Buy	+2,740	New	+$58.7K	0.01%	458
2023 Q4	–	Sell	-2,735	Closed	-$81.1K	–	1033
2023 Q3	$81.1K	Hold	2,735	–	–	0.01%	372
2023 Q2	$97.9K	Buy	2,735 +560	+26%	+$16.1K	0.01%	354
2023 Q1	$51K	Buy	+2,175	New	+$62.1K	0.01%	422
2022 Q4	–	Sell	-965	Closed	-$52K	–	1019
2022 Q3	$52K	Buy	965 +290	+43%	+$14.9K	0.01%	358
2022 Q2	$27K	Hold	675	–	–	﹤0.01%	394
2022 Q1	$45K	Hold	675	–	–	0.01%	405
2021 Q4	$68K	Buy	675 +85	+14%	+$8.79K	0.01%	380
2021 Q3	$74K	Buy	+590	New	+$70.1K	0.01%	393

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Manchester Capital Management's GH Position: Q2 2026 in Review

Manchester Capital Management opened a new position in Guardant Health (GH) in Q2 2026: 1 share worth $151. The stake represents ﹤0.01% of the portfolio and ranks #1292 among its holdings. This is a return to the name: Manchester Capital Management previously reported a position in GH as recently as Q2 2025.

Manchester Capital Management first reported a position in GH in Q3 2021 and has held it in 15 quarters since. The position peaked at $143K in Q2 2025. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Manchester Capital Management held 1 share of Guardant Health worth $151 as of Q2 2026.
Guardant Health was a new Manchester Capital Management position in Q2 2026.
Guardant Health made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1292 holding.
Manchester Capital Management first reported a position in Guardant Health in Q3 2021 and has held it in 15 quarters since.
Manchester Capital Management's Guardant Health position peaked at $143K in Q2 2025.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.